Abstract Submission Guidelines
All fields marked (*) must be completed to continue.
This form takes you through four (4) steps in order to submit an abstract for the 65th Annual World Congress of the ICA.
Step 1: Provide the correspondence author information.
Step 2: Insert the full abstract title and text (including tables) and select the abstract submission category.
Step 3: Detail all authors to be included.
Step 4: Review and submit the abstract.
Please ensure the text throughout is in lower case with the first letter capital where appropriate.
Once abstracts are submitted they cannot be accessed or amended.
ALL ACCEPTED PRESENTATIONS MUST HAVE THEIR PRESENTERS IN ATTENDANCE AT OUR ANNUAL MEETING. IF YOU ARE UNABLE TO BE PRESENT - DO NOT SUBMIT YOUR ABSTRACT. Abstract submission deadline is 1 JUNE 2024.
General Abstract Guidelines
ONLY ONE (1) ABSTRACT PER PRESENTER WILL BE CONSIDERED BY THE PROGRAM COMMITTEE - NO EXCEPTIONS
All scientific research referred to, reported, or used in a CME activity in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.
A maximum of 150 characters or approximately 15 words is permitted. A word count will automatically guide you.
Your abstract body should not exceed 2000 characters (including spaces) or approximately 200 words (excluding title and authors).
A word count will automatically guide you.
Please note, if you copy and paste an abstract, it will be automatically truncated at 2000 characters; therefore, check the end of your submitted abstract text.
1. Objectives. The overall purpose of the study and the research question*
2. Methods. The basic design of the study and the methodology used.*
3. Results. Major findings or trends found as a result of your analysis.*
4. Conclusions. A brief summary of your interpretations and conclusions.*
To withdraw an abstract submission, written notification must be sent to email@example.com. This notification must include the title, authors and affiliations (as submitted), phone, and e‐mail of the submitter. All requests for withdrawal MUST be made within 90 days of the annual meeting.
TERMS AND CONDITIONS OF ABSTRACT SUBMISSION
In order to have an abstract accepted for the ICA Meeting, all presenters must confirm compliance with the following:
YOUNG INVESTIGATOR AWARD COMPETITION
If you are a resident or fellow in a training program, consider applying for our Young Investigator Award Competition
The purpose of this competition is to encourage young physicians, research fellows and trainees to engage in high quality research, which forms the basis for future achievement in the pathophysiology of disease, diagnosis and treatment. The Scientific Committee will judge entries on originality, innovativeness, scientific merit, presentation, and relevance. The finalist will deliver a 15-minute oral presentation. The International College of Angiology reserves the right to publish the prize-winning manuscript in the International Journal of Angiology. The winner(s) will be given a cash award in the amount of USD $1000 and one-year Associate Membership in the International College of Angiology. Previous recipients of a Young Investigator Award will be ineligible.
The full manuscript MUST be submitted along with the abstract. The manuscript should conform to the guidelines for the International Journal of Angiology and should be 8 to 12 pages in length. Abstracts MUST be submitted in the format indicated on our abstract form. A signed disclosure statement MUST be submitted with your abstract. There are three awards in this category―medical, surgical and basic research. The purpose of the award is to encourage young physicians, surgeons and basic research scientists to engage in high quality research which forms the basis for future advancements in patient health care.
PHYSICIANS-IN-TRAINING, PhD STUDENTS, PA’S and NURSES ORAL AND POSTER PRESENTATION SUBMISSION
Trainees, interns, PA’s and nurses are invited to showcase your most interesting and challenging cases for educational purposes during our annual meeting. We are particularly interested in complex interventional and surgical cases that fall into the following categories:
Selection of cases for presentation―special emphasis is given to originality, innovation and creativity in diagnosis, therapy and management.
A prize in the amount of USD $100 will be awarded for the best case/poster presentation(s) by a trainee. In addition to a monetary prize, awardees will receive the remainder of the year’s membership as an Associate or Affiliate Member (whichever is applicable) for free. At the end of the year, the awardee is offered Associate Membership for 3-years or Affiliate Membership at a reduced annual fee. After 3-years as an Associate Member, you would submit an updated CV for elevation to a “full member” which would provide for an opportunity to be nominated for a position in a leadership role in the ICA.
IN SUBMITTING YOUR ABSTRACT, THE FOLLOWING INFORMATION IS COMPULSATORY:
The International College of Angiology requires that audiences at these educational programs be informed of a presenter’s (moderators, speakers, faculty, authors and contributors) academic and professional affiliations, as well as other commercial relationships relevant to the content of the material that is presented.
The policy allows the listener/attendee to be fully informed in evaluating the information being presented. The situations may include, but are not limited to 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan, 2) research grants, 3) employment (full or part time), 4) ownership or partnership, 5) consulting fees or other remuneration received by the presenter or his/her immediate family, including support that may be provided to attend the educational meeting, 6) non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson. The disclosure will be shown as an indication (by two **) for those presenters who have stated that a relationship(s) exists relevant to the topic(s) being discussed.
Indicate any author(s) who has a possible conflict of interest (see policy statement above) by two (2) ** next to that author(s) name in the heading of the abstract.
This program must insure balance, independence, objectivity, and scientific rigor in all educational activities. Faculty and planners participating in such activities must disclosure any significant financial interests or other relationships. Any potential conflicts of interest will be revealed and resolved in the course syllabus.
FINANCIAL RELATIONSHIPS, CONFLICTS OF INTEREST & OFF-LABEL DISCLOSURE POLICIES
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest: A potential conflict of interest exists when there is involvement between the speaker/presenter with any for-profit commercial form or organization (FPC). This includes, but is not limited to, one or more of the following: consultant, scientific advisory committee member; or lecturer for a FPC from which income is derived; officer, board member, trustee, owner or employee of an FPC; stock or bond holdings in an FPC (investments entirely managed by a third party such as mutual funds and pension plans are excluded); stock options held in an FPC.
Off-Label Disclosure (Including Generic Trade Names and Reporting Scientific Research): Presentations must give a balanced view of options. Faculty use of generic names will contribute to this impartiality. Presentations supported by any commercial entity reporting the results of scientific research must conform to the generally accepted standards of experimental design, data collection, and analysis. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is being discussed during an educational activity, it is required that the speaker disclose that the product is not labeled for the use under discussion or that the product is still investigational.
Disclosure of Relevant Financial Relationships
As a participant in the Annual World Congress of the International College of Angiology, we require everyone who is in a position to control the content of an educational activity must complete, sign and return the following disclosure statement upon the initiation of planning our educational activities. This disclosure statement must include all relevant financial relationships with any commercial interest within the past 12 months that could be perceived as a conflict of interest. Any individual who refuses to disclose relevant financial relationships will be disqualified from being planning committee member, a teacher or an author, and cannot have control of or responsibility for the development, management, presentation or evaluation of an educational activity.
International College of Angiology
Member, Council for International Organizations of Medical Sciences (CIOMS)
EXECUTIVE OFFICE: 161 MORIN DRIVE, JAY, VERMONT 05859-9283 U.S.A.
TELEPHONE: +802.988.4065 FAX: +802.988.4066
ICA EMAIL: firstname.lastname@example.org or email@example.com